First results of nivolumab (NIVO) plus ipilimumab (IPI) vs NIVO monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) from CheckMate 8HW.

被引：0

作者：

Andre, Thierry

Elez, Elena

Lenz, Heinz-Josef

Jensen, Lars Henrik

Touchefeu, Yann

Van Cutsem, Eric

Garcia-Carbonero, Rocio

Tougeron, David

Mendez, Guillermo

Schenker, Michael

de la Fouchardiere, Christelle

Limon, Maria Luisa

Yoshino, Takayuki

Li, Jin

Aubin, Francine

Cela, Elvis

Chen, Tian

Lei, Ming

Jin, Lixian

Lonardi, Sara

机构：

[1] Sorbonne Univ, Paris, France

[2] Hop St Antoine, Assistance Publ Hop Paris, Paris, France

[3] Vall Hebron Univ Hosp, Barcelona, Spain

[4] Inst Oncol VHIO, Barcelona, Spain

[5] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[6] Univ Hosp Southern Denmark, Vejle Hosp, Vejle, Denmark

[7] Ctr Hosp Univ Nantes, Nantes, France

[8] Univ Penn, Philadelphia, PA USA

[9] UCM, Hosp Univ 12 Octubre Imas12, Madrid, Spain

[10] Ctr Hosp Univ Poitiers Site Miletrie, Poitiers, France

[11] Hosp Univ Fdn Favaloro, Buenos Aires, Argentina

[12] Centrul Oncol Sf Nectarie, Craiova, Romania

[13] Univ Med & Pharm, Craiova, Romania

[14] Ctr Leon Berard, Lyon, France

[15] Hosp Univ Virgendel Rocio, Seville, Spain

[16] Natl Canc Ctr Hosp East Kashiwa, Chiba, Japan

[17] Shanghai East Hosp, Shanghai, Peoples R China

[18] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[19] Bristol Myers Squibb, Princeton, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.LBA143

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA143

引用

页码：LBA143 / LBA143

页数：1